Choosing which route to administer Semaglutide is discussed and can be either via injection of oral route
We can help determine if your current dose is still effective or if an adjustment is needed to manage side effects and maximize results
Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)
This approach may also help reduce symptoms such as belching or sulfuric (sulfur-like) burps
The Phase 2 clinical trial in postoperative-ileus patients used intravenous administration (PMID 25331030)
Typically, when cellular antioxidant defenses are compromised, unchecked lipid peroxides trigger ferroptosis (Su et al., 2020)